Advances in the pathogenesis of Goodpasture's disease: From epitopes to autoantibodies to effector T cells

Journal of Autoimmunity

Volumn 31, Issue 3, 2008, Pages 295-300

  Ooi, Joshua D ^a   Holdsworth, Stephen R ^a   Kitching, A Richard ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Autoantibodies; Cell mediated immunity; Glomerular basement membrane; Goodpasture's disease; MHC Class II; Type IV collagen

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; PROTEINASE;

ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; AUTOANTIGENS; COLLAGEN TYPE IV; EPITOPES, T-LYMPHOCYTE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTE SUBSETS;

EID: 56349098195     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.04.005     Document Type: Article

References (56)

1. Stanton M.C., and Tange J.D. Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis). Australas Ann Med 7 (1958) 132-144
2. Lerner R.A., Glassock R.J., and Dixon F.J. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126 (1967) 989-1004
3. McCoy R.C., Johnson H.K., Stone W.J., and Wilson C.B. Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21 (1982) 642-652
4. Saus J., Wieslander J., Langeveld J.P., Quinones S., and Hudson B.G. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263 (1988) 13374-13380
5. Leinonen A., Netzer K.O., Boutaud A., Gunwar S., and Hudson B.G. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain. Kidney Int 55 (1999) 926-935
6. Netzer K.O., Leinonen A., Boutaud A., Borza D.B., Todd P., Gunwar S., et al. The Goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J Biol Chem 274 (1999) 11267-11274
7. David M., Borza D.B., Leinonen A., Belmont J.M., and Hudson B.G. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope. J Biol Chem 276 (2001) 6370-6377
8. Sado Y., Boutaud A., Kagawa M., Naito I., Ninomiya Y., and Hudson B.G. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen. Kidney Int 53 (1998) 664-671
9. Borza D.B., Bondar O., Colon S., Todd P., Sado Y., Neilson E.G., et al. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem 280 (2005) 27147-27154
10. Yoshioka K., Iseki T., Okada M., Morimoto Y., Eryu N., and Maki S. Identification of Goodpasture antigens in human alveolar basement membrane. Clin Exp Immunol 74 (1988) 419-424
11. Zou J., Hannier S., Cairns L.S., Barker R.N., Rees A.J., Turner A.N., et al. Healthy individuals have Goodpasture autoantigen-reactive T cells. J Am Soc Nephrol 19 (2008) 396-404
12. Wong D., Phelps R.G., and Turner A.N. The Goodpasture antigen is expressed in the human thymus. Kidney Int 60 (2001) 1777-1783
13. Salama A.D., Chaudhry A.N., Ryan J.J., Eren E., Levy J.B., Pusey C.D., et al. In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol 12 (2001) 1908-1915
14. Yang R., Cui Z., Hellmark T., Segelmark M., Zhao M.H., and Wang H.Y. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 124 (2007) 207-212
15. Brainwood D., Kashtan C., Gubler M.C., and Turner A.N. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53 (1998) 762-766
16. Wang X.P., Fogo A.B., Colon S., Giannico G., Abul-Ezz S.R., Miner J.H., et al. Distinct epitopes for anti-glomerular basement membrane Alport alloantibodies and Goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. J Am Soc Nephrol 16 (2005) 3563-3571
17. Phelps R.G., and Rees A.J. The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 56 (1999) 1638-1653
18. Jones E.Y., Fugger L., Strominger J.L., and Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 6 (2006) 271-282
19. Phelps R.G., Jones V., Turner A.N., and Rees A.J. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunol 12 (2000) 1135-1143
20. Hopfer H., Maron R., Butzmann U., Helmchen U., Weiner H.L., and Kalluri R. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. Faseb J 17 (2003) 860-868
21. Chen L., Hellmark T., Wieslander J., and Bolton W.K. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats. Kidney Int 64 (2003) 2108-2120
22. Wu J., Borillo J., Glass W.F., Hicks J., Ou C.N., and Lou Y.H. T-cell epitope of alpha3 chain of type IV collagen induces severe glomerulonephritis. Kidney Int 64 (2003) 1292-1301
23. Bolton W.K., Chen L., Hellmark T., Fox J., and Wieslander J. Molecular mapping of the Goodpasture's epitope for glomerulonephritis. Trans Am Clin Climatol Assoc 116 (2005) 229-236 [discussion 37-8]
24. Robertson J., Wu J., Arends J., Glass II W.F., Southwood S., Sette A., et al. Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis. Kidney Int 68 (2005) 1061-1070
25. Arends J., Wu J., Borillo J., Troung L., Zhou C., Vigneswaran N., et al. T cell epitope mimicry in antiglomerular basement membrane disease. J Immunol 176 (2006) 1252-1258
26. Chen L., Hellmark T., Pedchenko V., Hudson B.G., Pusey C.D., Fox J.W., et al. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol 17 (2006) 3076-3081
27. Robertson J., Wu J., Arends J., Zhou C., McMahon J., Torres L., et al. Activation of glomerular basement membrane-specific B cells in the renal draining lymph node after T cell-mediated glomerular injury. J Am Soc Nephrol 16 (2005) 3256-3263
28. Cairns L.S., Phelps R.G., Bowie L., Hall A.M., Saweirs W.W., Rees A.J., et al. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol 14 (2003) 2801-2812
29. Zou J., Henderson L., Thomas V., Swan P., Turner A.N., and Phelps R.G. Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes. J Am Soc Nephrol 18 (2007) 771-779
30. Cui Z., and Zhao M.H. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol 116 (2005) 77-82
31. Sado Y., Naito I., and Okigaki T. Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from the urine of nephritic rats. J Pathol 158 (1989) 325-332
32. Dean E.G., Wilson G.R., Li M., Edgtton K.L., O'Sullivan K.M., Hudson B.G., et al. Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int 67 (2005) 566-575
33. Meyers K.E., Allen J., Gehret J., Jacobovits A., Gallo M., Neilson E.G., et al. Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int 61 (2002) 1666-1673
34. Sethi S., Lewin M., Lopez L., and Lager D. Linear anti-glomerular basement membrane IgG but no glomerular disease: Goodpasture's syndrome restricted to the lung. Nephrol Dial Transplant 22 (2007) 1233-1235
35. Kohda T., Okada S., Hayashi A., Kanzaki S., Ninomiya Y., Taki M., et al. High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis. Kidney Int 66 (2004) 177-186
36. Nakamura A., Yuasa T., Ujike A., Ono M., Nukiwa T., Ravetch J.V., et al. Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med 191 (2000) 899-906
37. Aitman T.J., Dong R., Vyse T.J., Norsworthy P.J., Johnson M.D., Smith J., et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439 (2006) 851-855
38. Fanciulli M., Norsworthy P.J., Petretto E., Dong R., Harper L., Kamesh L., et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39 (2007) 721-723
39. Reynolds J., and Pusey C.D. In vivo treatment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis in the BN rat. Clin Exp Immunol 95 (1994) 122-127
40. Kalluri R., Danoff T.M., Okada H., and Neilson E.G. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 100 (1997) 2263-2275
41. Neale T.J., Tipping P.G., Carson S.D., and Holdsworth S.R. Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet 2 (1988) 421-424
42. Bolton W.K., Innes Jr. D.J., Sturgill B.C., and Kaiser D.L. T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int 32 (1987) 869-876
43. Kitching A.R., Holdsworth S.R., and Tipping P.G. Crescentic glomerulonephritis-a manifestation of a nephritogenic Th1 response?. Histol Histopathol 15 (2000) 993-1003
44. Bolton W.K., Chandra M., Tyson T.M., Kirkpatrick P.R., Sadovnic M.J., and Sturgill B.C. Transfer of experimental glomerulonephritis in chickens by mononuclear cells. Kidney Int 34 (1988) 598-610
45. Bolton W.K., Tucker F.L., and Sturgill B.C. New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens. J Clin Invest 73 (1984) 1263-1276
46. Wu J., Hicks J., Borillo J., Glass II W.F., and Lou Y.H. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 109 (2002) 517-524
47. Reynolds J., Norgan V.A., Bhambra U., Smith J., Cook H.T., and Pusey C.D. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol 13 (2002) 359-369
48. Merkel F., Kalluri R., Marx M., Enders U., Stevanovic S., Giegerich G., et al. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int 49 (1996) 1127-1133
49. Reynolds J., Khan S.B., Allen A.R., Benjamin C.D., and Pusey C.D. Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Kidney Int 66 (2004) 1444-1452
50. Reynolds J., Prodromidi E.I., Juggapah J.K., Abbott D.S., Holthaus K.A., Kalluri R., et al. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 16 (2005) 1350-1359
51. Holdsworth S.R., Kitching A.R., and Tipping P.G. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 55 (1999) 1198-1216
52. Phoon R.K., Kitching A.R., Odobasic D., Jones L.K., Semple T.J., and Holdsworth S.R. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol 19 (2008) 477-485
53. Kitching A.R., Turner A.L., Semple T., Li M., Edgtton K.L., Wilson G.R., et al. Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma. J Am Soc Nephrol 15 (2004) 1764-1774
54. Wilson C.B., and Dixon F.J. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3 (1973) 74-89
55. Salama A.D., Chaudhry A.N., Holthaus K.A., Mosley K., Kalluri R., Sayegh M.H., et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int 64 (2003) 1685-1694
56. Wolf D., Hochegger K., Wolf A.M., Rumpold H.F., Gastl G., Tilg H., et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16 (2005) 1360-1370